SCHEMBL6706992

SCHEMBL6706992

Oc1nc2cccc(Cl)c2cc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 1/20 0.46
PDE3A Q14432 1/20 0.46
NQO2 P16083 1/20 0.42
CYP1A2 P05177 2/20 0.41
CYP2A6 P11509 2/20 0.41
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GLA P06280 1/20 0.39
ESRRB O95718 1/20 0.39
ESR1 P03372 1/20 0.39
ESRRA P11474 1/20 0.39
ESR2 Q92731 1/20 0.39
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
GBA1 P04062 1/20 0.37
GUSB P08236 1/20 0.37
PSMB8 P28062 2/20 0.36
PSMB5 P28074 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21404380 0.83 PSMB8 (0.41) PDE3BPDE3ANQO2CYP1A2MAOA
SCHEMBL21449661 0.79 BACE1 (0.41) PDE3BPDE3ANQO2CYP1A2CYP2A6
SCHEMBL2284036 0.75 ALDH1A1 (0.53) NQO2KDM4EALDH1A1GLAKMT2A
SCHEMBL30685964 0.75 ALDH1A1 (0.53) NQO2KDM4EALDH1A1GLAKMT2A
SCHEMBL26617970 0.74 KDM4E (0.56) PDE3BPDE3ANQO2KDM4EALDH1A1
SCHEMBL31345618 0.74 KDM4E (0.56) PDE3BPDE3ANQO2KDM4EALDH1A1
SCHEMBL4160733 0.73 ALDH1A1 (0.60) PDE3BPDE3ANQO2CYP1A2CYP2A6
SCHEMBL7045373 0.73 CYP1A2 (0.42) PDE3BPDE3ANQO2CYP1A2CYP2A6
SCHEMBL30914218 0.73 MAOA (0.45) CYP1A2CYP2A6MAOAMAOBKDM4E
SCHEMBL28475918 0.73 MAOA (0.45) CYP1A2CYP2A6MAOAMAOBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040044217-A1 Process to produce halo-4-phenoxyquinolines KRUMEL KARL LEOPOLD (US) 2004-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040044217-A1 Process to produce halo-4-phenoxyquinolines KCNQ4, CYP4X1, KCNQ2 PDE3B 1922/4885PDE3A 3084/4885NQO2 293/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.